“Proteasome Assembly Chaperone 3 Defines Metabolic-Immune Programs and Poor Prognosis in Breast Cancer via Multi-Omics Approaches”. (2026) 2026. Journal of Cancer 17 (3): 583-603.
Publications
2026
“Single-Cell and Transcriptomic Profiling Reveal Stemness-Driven Immune Evasion in Obstructive Sleep Apnea (OSA) Associated Lung Cancer”. 2026. Journal of Cancer 17 (2): 316-37.
Nguyen, NgocUyenNhi. 2026. “Multi-Omics and Single-Cell Dissection of Exostosin Glycosyltransferases (EXT1/EXT2) Reveals Divergent Oncogenic Roles and Therapeutic Vulnerabilities in Gliomas”. Journal of Cancer 17 (1): 177-96.
2025
Nguyen, NgocUyenNhi. 2025. “An FDA-Approved Drug Structurally and Phenotypically Corrects the K210del Mutation in Genetic Cardiomyopathy Models”. Journal of Clinical Investigation 32 (7): 1789-1804.
“Induced Cytokinesis Generates Highly Proliferative Mononuclear Cardiomyocytes at the Expense of Contractility”. 2025. Circulation 32 (7): 1789-1804.
Nguyen, NgocUyenNhi. 2025. “A Machine Learning Framework Using Urinary Biomarkers for Pancreatic Ductal Adenocarcinoma Prediction With post Hoc validation via Single-Cell Transcriptomics”. Briefings in Bioinformatics.
Nguyen, NgocUyenNhi. 2025. “Paracrine IGFBP3 Spatially Coordinates IGF Signaling to Induce Myocardial Regeneration in Mice”. Journal of Molecular and Cellular Cardiology.
2024
Nguyen, NgocUyenNhi. 2024. “Hypoxia-Induced Stabilization of HIF2A Promotes Cardiomyocyte Proliferation by Attenuating DNA Damage”. The Journal of Cardiovascular Aging 4.
Nguyen, NgocUyenNhi. 2024. “Identification of FDA-Approved Drugs That Induce Heart Regeneration in Mammals”. Nature Cardiovascular Research 3: 372–388.
“Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin Attenuates Sorafenib-Induced Myocardial Inflammation and Toxicity”. 2024. Environmental Toxicology 39: 4844-58.